UP

BioNTech aims to supply 2B COVID-19 vaccine doses this year

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The German pharma company BioNTech announced Monday that it is boosting its manufacturing capacity to be able to supply 2 billion doses of the coronavirus vaccine this year.

Axar.az reports that Dr. Ugur Sahin, the co-founder of BioNTech, gave details about the new investment plans of his company and its American partner Pfizer, in a presentation posted on the company's website.

“We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021,” he said.

“This is based on continuous process improvements and expansion at our current facilities, and contingent upon adding more suppliers as well as contract manufacturers,” he noted.

BioNTech, which has developed the world’s first effective jab against COVID-19, is currently producing the vaccines together with Pfizer in three manufacturing sites in the US and two other production facilities in Europe.

Date
2021.01.11 / 21:14
Author
Axar.az
See also

Harmanci: COVID-19 still present, caution needed

Millions at risk as US ends AIDS funding - UNAIDS report

Smart hydrogel developed to heal chronic wounds faster

WHO pushes bold reforms, launching 3 by 35 initiative

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Monkeypox case confirmed in Azerbaijan

WHO calls for international support to fund aid in Gaza

30 metapneumovirus cases reported in Kazakhstan

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla